in combination with other chemotherapeutics can reduce cancer resistance and recurrence and improve GBM patient survival.
No takes yet. Share an insight, caveat, or question.
Polewski et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: